Author:
Terpstra F.G.,Kleijn M.,Koenderman A.H.L.,Over J.,van Engelenburg F.A.C.,Schuitemaker H.,van 't Wout A.B.
Subject
Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Reference27 articles.
1. Plasma protein therapies: current and future perspectives;Farrugia;Best Pract Res Clin Haematol,2006
2. Current and future therapy for hereditary angioedema;Zuraw;Clin Immunol,2005
3. C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema;Caliezi;Pharmacol Rev,2000
4. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990–2000;Chiavetta;CMAJ,2003
5. Risque résiduel de transmission du VIH, du VHC et du VHB par transfusion sanguine entre 1992 et 2002 en France et impact du dépistage génomique viral
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献